Organic Active Ingredients TRIZ Cases

Biodegradable polyesters incorporate NSAIDs as pendant groups to deliver sustained drug action while minimizing gastrointestinal side effects.

Novel linker structure conjugates to two antibody thiol groups forming a stable disulfide-like bond for homogeneous drug delivery.

Combining an insoluble FXR agonist with polyvinylpyrrolidone improves dissolution rates while avoiding high temperature degradation.

Ingested carbohydrate clathrates form inclusion complexes that interact with aquaporins to increase water permeation.

MicroRNA-129 expression levels diagnose colorectal cancer progression and overcome chemotherapy resistance by modulating BCL2, E2F3, and thymidylate synthase.

Imidopiperidine compounds inhibit human polynucleotide kinase phosphatase to overcome cancer cell DNA repair resistance.

Isotopic substitution at specific carbon positions slows cytochrome P450 metabolism, extending half-life and reducing toxic metabolite production.

Pyrazole derivatives inhibit kinase activity, reducing tumor growth and vascularization by targeting angiogenesis pathways.

MicroRNA inhibitors intercept premalignant pancreatic lesions by downregulating KRAS signaling, preventing invasive tumor development.

Administering a BACE1 inhibitor suppresses excessive cytokine release to attenuate severe inflammation and organ damage in cytokine storm conditions.

Composite arylalkylamine formulation uses coating films and diluents to resolve light and heat instability in hyperparathyroidism treatments.

Alkyl substituted triazole compounds activate the APJ receptor to improve cardiac contractility and ejection fraction.

Combining vitamin E with a polyphenol source resolves the trade-off between feeding costs and offspring productivity by optimizing antioxidant status.

Combining dextran sulfate with heparin creates a synergistic pharmaceutical agent that targets thromboinflammatory pathways.

Formula I compounds inhibit JAK2 enzyme activity with high specificity, reducing off-target effects caused by broad-spectrum inhibition.

Blocking the RGMb-NEO1-BMP signaling pathway reverses established airway hyperreactivity and chronic inflammation in asthma patients.

Targeting conserved p97 resolves remdesivir limitations by enabling broad-spectrum treatment across multiple coronavirus strains.

Segmented drug delivery core uses swelling polymer and gas agent to float, maintaining physical integrity for prolonged gastric retention.

Selective small molecule inhibitors block shared epitope-calreticulin interactions, preventing bone erosion and reducing side effects in rheumatoid arthritis.

SCY-078 citrate and hippurate salts improve kinetic solubility while controlling hygroscopicity for stable solid dosage forms.

Zwitterionic and tromethamine salt forms of FXR agonists resolve stability-bioavailability trade-offs for NASH treatment.

A Tie-2 activator reduces intraocular pressure by stabilizing the trabecular meshwork vasculature.

Substituted quinazoline compounds inhibit dipeptidyl peptidase-IV activity, improving glucose regulation and reducing complications in type 2 diabetes.

An implantable pump maintains osteoinductive factor concentration in a carrier matrix, preventing degradation and sustaining bone healing efficacy.

A crystalline form of 6-[(4R)-4-methyl-1,1-dioxido-1,2,6-thiadiazinan-2-yl]isoquinoline-1-carbonitrile prepared via acetone crystallization.

Combines dsRNA polyplexes with checkpoint antibodies to activate innate immunity and induce interferon secretion.

Combining romidepsin with gemcitabine overcomes resistance in Ras-expressing pancreatic and colorectal cancers via synergistic tumor growth inhibition.

A trans-fluorinated radiolabeled inhibitor enables non-invasive PET imaging of CDK4/6 expression in cancer cells.

Tricyclic compounds inhibit mutant IDH enzymes, reducing 2-HG levels to treat cancers associated with neomorphic activity.

Novel compounds bind specifically to human serum albumin for targeted purification and therapeutic half-life extension.

Alu repeat RNA induces interferon lambda at mucosal barriers to resolve insufficient pathogen defense.

A multi-layer implantable device uses an intermediate acrylate polymer coating to control the release of active pharmaceutical ingredients.

Cationic oil-in-water emulsions anchor nucleic acids to lipid particles, protecting RNA from nuclease degradation and extending half-life.

Aminoheteroaryl benzodiazepines synthesized through cyclization to produce effective respiratory syncytial virus inhibitors.

Isotopic substitution of deuterium reduces nephrotoxicity while maintaining cognitive function improvement for neuropsychiatric disorders.

RNAi oligonucleotides reduce CTNNB1 expression to increase bile duct capacity and lower bile acid synthesis, resolving liver damage from paucity.

Hydrolysis of a degradable polymer creates an acidic microclimate that sustains amide release at the joint site, reducing dosing frequency.

A DNA vaccine encoding CTLA-4 or PD-L1 induces specific immunity against infectious and malignant diseases.

Composite fiber complex increases gastrointestinal viscosity to improve insulin sensitivity and lower blood glucose levels.

Pharmacodynamic dosing with optimized voclosporin isomers achieves higher complete remission rates while minimizing side effects compared to standard care.

Segmented molecular design of cyclic guanidinyl compounds resolves the trade-off between therapeutic effectiveness and synthesis complexity.

Engineered lipid A molecules from Moritella bacteria reduce severe side effects by tuning acyl chains to control immune activation levels.

Arginine and zinc salts stabilize chlorhexidine, preventing degradation and maintaining antibacterial efficacy.

Conjugating a TLR9 targeting ligand with lenalidomide sensitizes non-del(5q) MDS cells, resolving limited treatment efficacy.

New heterocyclic compounds act as selective CGRP receptor antagonists, reducing liver toxicity while treating neurogenic inflammation.

Imidazo[1,2-b][1,2,4]triazol derivatives selectively modulate Nurr1 and Nur77 receptors to inhibit cancer cell growth while sparing healthy cells.

Porous carrier adsorbs active ingredient dispersion to improve bioavailability of poorly water-soluble drugs.

Pyrimidinyl-piperazine ligands target dopamine D3 and D2 receptors to treat schizophrenia while avoiding extrapyramidal symptoms.

Merges PD-1 antagonism with ALK inhibition to overcome immune evasion and ALK-driven resistance in NSCLC.

Tyrosine analogue derivatives inhibit Rho Kinase enzymes to resolve selectivity trade-offs for pulmonary disease treatment.

PNPase synthesizes single-stranded RNA strands that hybridize into therapeutic double-stranded RNA, enabling non-invasive nasal or oral delivery.

Polyaspartic acid binds polymyxins via electrostatic interactions to form inhalable dry powder complexes.

SLC-391 inhibits AXL kinase to block SARS-CoV-2 spike protein interaction with ACE2, reducing viral replication in epithelial cells.

Epsilon-N-(gamma-glutamyl)lysine stimulates hair papilla cell proliferation to enhance hair growth.

Azomethine ylide reacts with E-stilbene derivatives to form trans-pyrrolidine intermediates, enabling reliable industrial-scale asenapine synthesis.

Selective 2-azaspiro[3.4]octane M4 agonists treat psychosis by regulating dopamine signaling while avoiding cholinergic side effects.

Merges chlorogenic acid with carnosic acid to lower oxidized LDL levels while eliminating synthetic side effects.

Citric acid chemically cross-links carboxymethylcellulose, preventing reversible physical degradation under varying pH and mechanical loading.

Reconstituted HDL nanoparticles encapsulate hydrophobic HYNIC conjugates to transport radioisotopes via receptor-mediated endocytosis.

HPK1 inhibitors suppress kinase activity to boost CAR-T cell cytotoxicity while minimizing side effects from organ expression.

Preterm infant formulas with optimized phenylalanine levels resolve amino acid balance issues while maintaining adequate protein intake for healthy development.

Targeting Brd4 isoform B sensitizes tumor cells to DNA damage while protecting healthy tissue.

5-position modified uridines provide nuclease resistance and stability to oligonucleotides without increasing synthesis complexity.

Tannic acid compositions with specific galloyl moieties inhibit D-amino acid oxidase activity to treat central nervous system disorders.

Replacing the DNA strand tail with a longer telomere sequence extends health span while avoiding cancerous cell growth risks.

Direct administration of 8,9-unsaturated sterols increases oligodendrocyte formation to address insufficient remyelination in neurological diseases.

Heterocyclic PAR4 antagonists inhibit platelet aggregation with nanomolar potency, addressing partial efficacy and bleeding risks in thromboembolic therapy.

Phosphate compounds inhibit anti-apoptotic activity of Bcl-2 family proteins, resolving chemoresistance in cancer and autoimmune diseases.

Vidofludimus combines DHODH inhibition and Nurr1 agonism to address progression independent of relapse activity in multiple sclerosis.

Isoquinoline analogues modify ribavirin cores to treat respiratory syncytial virus infections while reducing mutagenicity risks.

Custom-formulated cosmetic compositions incorporate extracts from rejuvenated cells to address ineffective individualized skin and hair rejuvenation.

Formula 1 compounds boost sodium iodide symporter expression, restoring radioactive iodine therapy efficacy for resistant anaplastic thyroid cancer.

Formula I compounds modulate EP300 and CBP proteins, addressing the lack of approved inhibitors for treating acute myeloid leukemia.

Coated nuclear particles containing a CDK9 inhibitor and surfactant improve flowability while suppressing agglomeration.

TAS-108 binds estrogen receptor alpha to reduce blood pressure without affecting normotensive individuals.

Antibodies targeting the KIT receptor D4 domain inhibit abnormal kinase activity, addressing limited treatment effectiveness in KIT-associated disorders.

Substituted heterocyclic compounds inhibit the PRMT5 enzyme to address insufficient potency in current anti-cancer therapies.

Cannabidiol quinol derivatives inhibit prolyl hydroxylase activity to stabilize hypoxia-inducible factor protein levels.

Biodegradable nanoparticle carriers provide prolonged buprenorphine release, reducing administration frequency and abuse potential.

MicroRNA signatures validate molecular assay results, reducing false positive rates caused by sample contamination during low-virulence infection diagnosis.

Modified griseofulvin compounds cross the blood-brain barrier to treat neurodegenerative disorders while maintaining peripheral efficacy.

Deuterated VX-661 strengthens carbon-deuterium bonds, slowing CYP-mediated metabolism and reducing toxic metabolite formation.

Calixpyrrole derivatives overcome limited delivery by leveraging the enhanced permeation and retention effect of neoplastic vasculature.

Cyclic conjugated peptides bind GPIbα to prevent rapid clearance, extending cold-stored platelet shelf life beyond 48 hours.

A gas cannula delivers pressurized medical air in a laminar flow pattern to displace sub-retinal hemorrhages away from the macula.

Combines autophagy modulators with cyclin-dependent kinase inhibitors to enhance cytotoxicity against chronic lymphocytic leukemia cells.

Nucleophilic agents replace tedious dialysis cycles to deplete toxic epoxide impurities in crosslinked polysaccharide gels.

Triazole carboxamide derivatives bind selectively to trace amine associated receptors.

Segmented cyclic compounds inhibit TREX1 to treat autoimmune conditions without complex synthesis.

Extraction systems remove active compounds from plant matter to enable precise re-addition, resolving variable concentration issues in microdosing applications.

Substituted quinazoline prodrugs release nitric oxide to increase ApoA-I levels and improve lipid metabolism.

Inhibitory nucleic acids reduce vimentin, RLTPR, and PKC-θ proteins in regulatory T-cells to enhance suppressive potency.

A multi-layer oral thin film connects polymer layers via a stitched seam to enable rapid dissolution and layer marking.